Taysha Gene Therapies, Inc.

TSHA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$139,036$143,940$87,880$149,103
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,094$5,928$8,537$10,499
Total Curr. Assets$142,130$149,868$96,417$159,602
Property Plant & Equip (Net)$15,866$20,408$25,906$50,610
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$2,637
Tax Assets$0$0$0$0
Other NC Assets$2,368$2,455$3,953$1,107
Total NC Assets$18,234$22,863$29,859$54,354
Other Assets$0$0$0$0
Total Assets$160,364$172,731$126,276$213,956
Liabilities
Payables$3,592$6,366$10,946$21,763
Short-Term Debt$1,877$1,646$1,521$0
Tax Payable$0$0$0$0
Deferred Revenue$9,773$18,106$33,557$0
Other Curr. Liab.$10,985$10,638$16,766$29,983
Total Curr. Liab.$26,227$36,756$62,790$51,746
LT Debt$61,303$59,461$58,407$63,092
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,309$1,577$4,130$3,735
Total NC Liab.$62,612$61,038$62,537$66,827
Other Liabilities$0$0$0$0
Cap. Leases$19,238$20,599$21,961$25,900
Total Liabilities$88,839$97,794$125,327$118,573
Equity
Pref Stock$0$0$0$0
Common Stock$2$2$1$0
Retained Earnings-$602,305-$513,007-$401,441-$235,649
AOCI-$4,031$0$0$0
Other Equity$677,859$587,942$402,389$331,032
Total Equity$71,525$74,937$949$95,383
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$160,364$172,731$126,276$213,956
Net Debt-$75,856-$82,833-$27,952-$86,011